阿根廷农业生物技术年报(2011)

阿根廷仍然是继美国和巴西之后第三大生物技术作物生产国，产量占到全球生物技术作物产量的15%。2011年5月19日，阿根廷政府批准先正达公司研发的转基因玉米MIR162可以进行生产和商业化，该产品在欧洲尚未获批，这一举措代表着阿根廷向着欧盟的“镜子政策”的反方向迈出了一步。为了找到一种承认知识产权的机制，孟山都公司制订了（在种子行业的支持下）与农民签署的私人协议。到目前为止，3 640个农民签署了协议，占到种植总面积的31.5%.

Argentina Agricultural Biotechnology Annual (2011)

Argentina continues to be the third largest producer of biotech crops after the United States and Brazil, producing 15 percent of the world s biotech production. On May 19, 2011, the government approved Syngenta s corn event MIR162 for production and commercialization and as the event is not yet approved in Europe, this represents a step forward against the “mirror policy” with the European Union. In an effort to move forward in finding a mechanism to recognize intellectual property rights, Monsanto (with support of the seed industry) developed a private agreement with farmers. Up until now, 3 640 farmers have signed the agreement, which represents 31.5 percent of the total area.